Consistent with accelerating APOE4-dependent risk for AD and cognitive decline with older age [17], some studies have reported stronger effects of APOE4 on WM microstructure with age [3, 15, 18], whereas others observed no such interaction [8]. This evidence concerns the gene APOE and Alzheimer disease.